Literature DB >> 6294653

Differential subcellular localization of in vivo-phosphorylated and nonphosphorylated middle-sized tumor antigen of polyoma virus and its relationship to middle-sized tumor antigen phosphorylating activity in vitro.

K Segawa, Y Ito.   

Abstract

A small fraction of polyoma virus middle-sized tumor (T) antigen is phosphorylated in vivo, resulting in a small amount of phosphotyrosine and phosphothreonine and significantly larger amounts of phosphoserine. When infected cells are separated into nuclear, plasma membrane, and low-speed supernatant fractions, 80-95% of in vivo-phosphorylated middle-sized T antigen is localized to the plasma membrane fraction, while 25-50% of [35S]methionine-labeled middle-sized T antigen is found in the nuclear fraction and the same amount is found in the plasma membrane fraction. Immunoprecipitated T antigens contain a protein kinase activity that phosphorylates middle-sized T antigen at tyrosine residues. Eighty to 90% of this activity is located in the plasma membrane fraction. When immunoprecipitated T antigens are treated with alkaline phosphatase, middle-sized T antigen-phosphorylating activity decreases as 32PO4 is lost from in vivo 32P-labeled middle-sized T antigen. The possibility that in vivo-phosphorylated middle-sized T antigen located in the plasma membrane is an active tyrosine-specific kinase is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294653      PMCID: PMC347223          DOI: 10.1073/pnas.79.22.6812

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus-coded and important for cell transformation.

Authors:  Y Ito
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

3.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

4.  Polyoma virus--a study of wild-type, mutant and defective DNAs.

Authors:  M Fried; B E Griffin; E Lund; D L Robberson
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

5.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation.

Authors:  M S Collett; E Erikson; R L Erikson
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

7.  Isolation of plasma membrane from tissue culture--L cells.

Authors:  L Warren
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

8.  Simian virus 40 gene A regulates the association between a highly phosphorylated protein and chromatin and ribosomes in simian virus 40-transformed cells.

Authors:  K Segawa; N Yamaguchi; K Oda
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

9.  Characterization of polyoma virus T antigen.

Authors:  Y Ito; N Spurr; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  30 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  12-O-tetradecanoylphorbol-13-acetate stimulates phosphorylation of the 58,000-Mr form of polyomavirus middle T antigen in vivo: implications for a possible role of protein kinase C in middle T function.

Authors:  J T Matthews; T L Benjamin
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity.

Authors:  B J Druker; L E Ling; B Cohen; T M Roberts; B S Schaffhausen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Multicopy plasmid with a structure related to the polyoma virus genome.

Authors:  T Kusano; H Uehara; H Saito; K Segawa; M Oishi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Cooperation of middle and small T antigens of polyomavirus in transformation of established fibroblast and epithelial-like cell lines.

Authors:  T Noda; M Satake; Y Yamaguchi; Y Ito
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

6.  Transformation by viral and cellular oncogenes of a mouse BALB/3T3 cell mutant resistant to transformation by chemical carcinogens.

Authors:  M Ono; M Yakushinji; K Segawa; M Kuwano
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

7.  Significance of the gastrin homology and surrounding sequences in polyomavirus middle T antigen for cell transformation.

Authors:  K L Clark; W R Folk
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

8.  Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts.

Authors:  L Raptis; H Lamfrom; T L Benjamin
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

9.  In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.

Authors:  W Markland; S H Cheng; B A Oostra; A E Smith
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

10.  Phosphorylation in vitro of Escherichia coli-produced 235R and 266R tumor antigens encoded by human adenovirus type 12 early transformation region 1A.

Authors:  L A Lucher; P M Loewenstein; M Green
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.